Email This Article
CVS to Pay $20 Million to Settle SEC Accounting Violations
CVS Caremark has agreed to pay $20 million to settle charges from the Securities and Exchange Commission that the drug store giant misled investors about significant financial setbacks and used improper accounting that artificially boosted its financial performance.
Login for Registered Users:
Log in below to email an article: